Adoptive immunotherapy against experimental visceral leishmaniasis with CD8+ T cells requires the presence of cognate antigen

Infect Immun. 2006 Jan;74(1):773-6. doi: 10.1128/IAI.74.1.773-776.2006.

Abstract

CD8+ T cells have a protective role in experimental visceral leishmaniasis. However, the observation that inflammatory cytokines induce bystander activation of CD8+ T cells questions the need for antigen-dependent effector function. Here, we demonstrate that successful adoptive immunotherapy with CD8+ T cells is strictly dependent upon the presence of cognate antigen.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Protozoan / immunology*
  • CD8-Positive T-Lymphocytes / immunology*
  • Immunotherapy, Adoptive*
  • Leishmania donovani / genetics
  • Leishmania donovani / immunology*
  • Leishmaniasis, Visceral / immunology*
  • Leishmaniasis, Visceral / therapy*
  • Mice
  • Mice, Transgenic
  • Ovalbumin / biosynthesis
  • Ovalbumin / genetics

Substances

  • Antigens, Protozoan
  • Ovalbumin